Sensei Biotherapeutics is a brand that follows the teachings of the immune system to discover groundbreaking treatments that empower the body to combat cancer. By harnessing the principles of cancer's design, Sensei Biotherapeutics has developed a robust pipeline of investigational therapies that are specifically designed to target the tumor microenvironment. These conditionally active antibodies have the potential to unlock previously untargetable areas and provide new hope for cancer patients.

Sensei Biotherapeutics operates with a unique approach, driven by the understanding that the properties of the tumor microenvironment present an opportunity to develop highly selective therapeutics. Their innovative products are expected to revolutionize cancer treatment by offering novel options for patients who face challenging immuno-oncology targets. With headquarters in Rockville, MD and a presence in Boston, MA, Sensei Biotherapeutics is dedicated to transforming the lives of cancer patients worldwide.

Their commitment to advancing the field of oncology underscores their position as leaders in the fight against cancer